295 related articles for article (PubMed ID: 21796633)
1. Ten-year survival among HIV-1-infected subjects with AIDS or non-AIDS-defining malignancies.
Spagnuolo V; Galli L; Salpietro S; Gianotti N; Guffanti M; Cossarini F; Bigoloni A; Cinque P; Bossolasco S; Travi G; Fumagalli L; Lazzarin A; Castagna A
Int J Cancer; 2012 Jun; 130(12):2990-6. PubMed ID: 21796633
[TBL] [Abstract][Full Text] [Related]
2. Overview of cancer incidence and mortality among people living with HIV/AIDS in British Columbia, Canada: Implications for HAART use and NADM development.
Chiu CG; Smith D; Salters KA; Zhang W; Kanters S; Milan D; Montaner JSG; Coldman A; Hogg RS; Wiseman SM
BMC Cancer; 2017 Apr; 17(1):270. PubMed ID: 28410587
[TBL] [Abstract][Full Text] [Related]
3. Use of statins and risk of AIDS-defining and non-AIDS-defining malignancies among HIV-1 infected patients on antiretroviral therapy.
Galli L; Spagnuolo V; Poli A; Salpietro S; Gianotti N; Cossarini F; Carbone A; Nozza S; Bossolasco S; Bigoloni A; Lazzarin A; Castagna A
AIDS; 2014 Oct; 28(16):2407-15. PubMed ID: 25160933
[TBL] [Abstract][Full Text] [Related]
4. Characteristics of non-AIDS-defining malignancies in the HAART era: a clinico-epidemiological study.
Dauby N; De Wit S; Delforge M; Necsoi VC; Clumeck N
J Int AIDS Soc; 2011 Mar; 14():16. PubMed ID: 21443771
[TBL] [Abstract][Full Text] [Related]
5. Lung cancer in HIV positive patients: the GICAT experience.
Bearz A; Vaccher E; Martellotta F; Spina M; Talamini R; Lleshi A; Cacopardo B; Nunnari G; Berretta M; Tirelli U;
Eur Rev Med Pharmacol Sci; 2014; 18(4):500-8. PubMed ID: 24610616
[TBL] [Abstract][Full Text] [Related]
6. Non-Hodgkin's lymphoma in patients with human immunodeficiency virus infection in Taiwan.
Yang CJ; Chen MY; Hsieh SM; Sheng WH; Sun HY; Hung CC; Chang SC
J Microbiol Immunol Infect; 2010 Aug; 43(4):278-84. PubMed ID: 20688287
[TBL] [Abstract][Full Text] [Related]
7. Epidemiologic trends of cancer diagnoses among HIV-infected children in Spain from 1997 to 2008.
Alvaro-Meca A; Micheloud D; Jensen J; Díaz A; García-Alvarez M; Resino S
Pediatr Infect Dis J; 2011 Sep; 30(9):764-8. PubMed ID: 21494172
[TBL] [Abstract][Full Text] [Related]
8. Malignancy-related causes of death in human immunodeficiency virus-infected patients in the era of highly active antiretroviral therapy.
Bonnet F; Lewden C; May T; Heripret L; Jougla E; Bevilacqua S; Costagliola D; Salmon D; Chêne G; Morlat P
Cancer; 2004 Jul; 101(2):317-24. PubMed ID: 15241829
[TBL] [Abstract][Full Text] [Related]
9. HIV-induced immunodeficiency and mortality from AIDS-defining and non-AIDS-defining malignancies.
Monforte Ad; Abrams D; Pradier C; Weber R; Reiss P; Bonnet F; Kirk O; Law M; De Wit S; Friis-Møller N; Phillips AN; Sabin CA; Lundgren JD;
AIDS; 2008 Oct; 22(16):2143-53. PubMed ID: 18832878
[TBL] [Abstract][Full Text] [Related]
10. The changing pattern of AIDS-defining illnesses with the introduction of highly active antiretroviral therapy (HAART)in a London clinic.
Ives NJ; Gazzard BG; Easterbrook PJ
J Infect; 2001 Feb; 42(2):134-9. PubMed ID: 11531320
[TBL] [Abstract][Full Text] [Related]
11. HIV-related malignancies pre- and post-highly active antiretroviral therapy: experiences in an inner city tertiary referral centre.
Kiely B; O'Flaherty J; Surah S; Kieran J; O'Donnell D; Bergin C; Mulcahy F
Int J STD AIDS; 2010 May; 21(5):332-6. PubMed ID: 20498102
[TBL] [Abstract][Full Text] [Related]
12. Spectrum of AIDS defining & non-AIDS defining malignancies in north India.
Sachdeva RK; Sharma A; Singh S; Varma S
Indian J Med Res; 2016 May; 143(Supplement):S129-S135. PubMed ID: 27748287
[TBL] [Abstract][Full Text] [Related]
13. AIDS-related Kaposi's Sarcoma: evaluation of potential new prognostic factors and assessment of the AIDS Clinical Trial Group Staging System in the Haart Era--the Italian Cooperative Group on AIDS and Tumors and the Italian Cohort of Patients Naive From Antiretrovirals.
Nasti G; Talamini R; Antinori A; Martellotta F; Jacchetti G; Chiodo F; Ballardini G; Stoppini L; Di Perri G; Mena M; Tavio M; Vaccher E; D'Arminio Monforte A; Tirelli U;
J Clin Oncol; 2003 Aug; 21(15):2876-82. PubMed ID: 12885804
[TBL] [Abstract][Full Text] [Related]
14. Ten years later: a single hospital experience with malignancy in HIV/AIDS.
Reed M; Cosgrove JM; Cindrich R; Parithivel VS; Gad Y; Bangalore M; Uzor R; Kalim J; Segura R; Albu E
J Surg Oncol; 2010 Sep; 102(3):282-6. PubMed ID: 20740588
[TBL] [Abstract][Full Text] [Related]
15. Clinical features and predictors of survival of AIDS-related non-Hodgkin's lymphoma in a population-based case series in Sydney, Australia.
Robotin MC; Law MG; Milliken S; Goldstein D; Garsia RJ; Dolan GM; Kaldor JM; Grulich AE
HIV Med; 2004 Sep; 5(5):377-84. PubMed ID: 15369514
[TBL] [Abstract][Full Text] [Related]
16. [Malignancies in HIV-infected patients: descriptive study of 129 cases between 1993 and 2010].
Meijide H; Mena A; Pernas B; Castro A; López S; Vázquez P; Bello L; Baliñas J; Rodríguez-Martínez G; Pedreira JD
Rev Chilena Infectol; 2013 Apr; 30(2):156-61. PubMed ID: 23677154
[TBL] [Abstract][Full Text] [Related]
17. AIDS malignancies in the era of highly active antiretroviral therapy.
Gates AE; Kaplan LD
Oncology (Williston Park); 2002 May; 16(5):657-65; discussion 665, 668-70. PubMed ID: 12108891
[TBL] [Abstract][Full Text] [Related]
18. Survival in HIV-infected patients after a cancer diagnosis in the cART Era: results of an italian multicenter study.
Gotti D; Raffetti E; Albini L; Sighinolfi L; Maggiolo F; Di Filippo E; Ladisa N; Angarano G; Lapadula G; Pan A; Esposti AD; Fabbiani M; Focà E; Scalzini A; Donato F; Quiros-Roldan E;
PLoS One; 2014; 9(4):e94768. PubMed ID: 24760049
[TBL] [Abstract][Full Text] [Related]
19. Malignancies in HIV: pre- and post-highly active antiretroviral therapy.
Nutankalva L; Wutoh AK; McNeil J; Frederick WR; Reddy RB; Daftary M; Gentles A; Addae-Afoakwa K
J Natl Med Assoc; 2008 Jul; 100(7):817-20. PubMed ID: 18672558
[TBL] [Abstract][Full Text] [Related]
20. AIDS-related malignancies: emerging challenges in the era of highly active antiretroviral therapy.
Cheung MC; Pantanowitz L; Dezube BJ
Oncologist; 2005; 10(6):412-26. PubMed ID: 15967835
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]